195 related articles for article (PubMed ID: 35399074)
1. Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study.
Ayyagari V; Li M; Pasman Z; Wang X; Louis S; Diaz-Sylvester P; Groesch K; Wilson T; Brard L
BMC Cancer; 2022 Apr; 22(1):387. PubMed ID: 35399074
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of sterol‑o‑acyl transferase 1 and cholesterol ester levels in plasma, peritoneal fluid and tumor tissue of patients with endometrial cancer: A pilot study.
Ayyagari VN; Li M; Diaz-Sylvester P; Groesch K; Wilson T; Pasman Z; Shah EM; Braundmeier-Fleming A; Brard L
Oncol Lett; 2023 Jun; 25(6):231. PubMed ID: 37153054
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the clinicopathological relevance of mesothelin level in plasma, peritoneal fluid, and tumor tissue of epithelial ovarian cancer patients.
Okła K; Surówka J; Frąszczak K; Czerwonka A; Kaławaj K; Wawruszak A; Kotarski J; Wertel I
Tumour Biol; 2018 Oct; 40(10):1010428318804937. PubMed ID: 30319054
[TBL] [Abstract][Full Text] [Related]
4. [Preliminary study on the diagnostic value of serum-derived exosomal lncRNA in epithelial ovarian cancer].
Li YW; Li L
Zhonghua Fu Chan Ke Za Zhi; 2022 Mar; 57(3):198-209. PubMed ID: 35385957
[No Abstract] [Full Text] [Related]
5. Plasma circN4BP2L2 is a promising novel diagnostic biomarker for epithelial ovarian cancer.
Ning L; Lang J; Wu L
BMC Cancer; 2022 Jan; 22(1):6. PubMed ID: 34980005
[TBL] [Abstract][Full Text] [Related]
6. High Expression of MicroRNA-200a/b Indicates Potential Diagnostic and Prognostic Biomarkers in Epithelial Ovarian Cancer.
Zhang B; Li Y; Li Y; Zhao H; An R
Dis Markers; 2022; 2022():2751696. PubMed ID: 35371343
[TBL] [Abstract][Full Text] [Related]
7. Study on early diagnosis of epithelial ovarian cancer by analysis of plasma septin-9 and clusterin level.
Lyu N; Wang Y; Wang J; Zhang Z; Kong W
J Cancer Res Ther; 2018 Jun; 14(Supplement):S444-S449. PubMed ID: 29970704
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of circN4BP2L2 in type I and type II epithelial ovarian cancer.
Ning L; Lang J; Long B; Wu L
BMC Cancer; 2022 Nov; 22(1):1210. PubMed ID: 36434559
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer.
Ma RQ; Tang ZJ; Ye X; Cheng HY; Sun KK; Chang XH; Cui H
Arch Gynecol Obstet; 2018 May; 297(5):1235-1244. PubMed ID: 29428978
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA Expression Profiling of Epithelial Ovarian Cancer Identifies New Markers of Tumor Subtype.
Rattanapan Y; Korkiatsakul V; Kongruang A; Siriboonpiputtana T; Rerkamnuaychoke B; Chareonsirisuthigul T
Microrna; 2020; 9(4):289-294. PubMed ID: 32703147
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer.
Ma Z; Wang X; He J; Xia J; Li Y
PLoS One; 2017; 12(3):e0174037. PubMed ID: 28355289
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
Zeng S; Liu S; Feng J; Gao J; Xue F
Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Multimerin 1 (MMRN1) expression in ovarian cancer.
Saini A; Chandra KB; Kumar V; Mathur SR; Sharma JB; Kumar S; Yadav S
Mol Biol Rep; 2020 Dec; 47(12):9459-9468. PubMed ID: 33263168
[TBL] [Abstract][Full Text] [Related]
16. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.
Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K
Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366
[TBL] [Abstract][Full Text] [Related]
17. The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer.
Zuberi M; Khan I; Gandhi G; Ray PC; Saxena A
Tumour Biol; 2016 Aug; 37(8):11259-66. PubMed ID: 26951510
[TBL] [Abstract][Full Text] [Related]
18. Long Noncoding RNA LINC01554 as a Novel Biomarker for Diagnosis and Prognosis Prediction of Epithelial Ovarian Cancer.
Luo T; Jiang Y; Yang J
Dis Markers; 2021; 2021():1244612. PubMed ID: 34422133
[TBL] [Abstract][Full Text] [Related]
19. Assessment of peritoneal microbial features and tumor marker levels as potential diagnostic tools for ovarian cancer.
Miao R; Badger TC; Groesch K; Diaz-Sylvester PL; Wilson T; Ghareeb A; Martin JA; Cregger M; Welge M; Bushell C; Auvil L; Zhu R; Brard L; Braundmeier-Fleming A
PLoS One; 2020; 15(1):e0227707. PubMed ID: 31917801
[TBL] [Abstract][Full Text] [Related]
20. PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer.
Ma R; Ye X; Cheng H; Ma Y; Cui H; Chang X
Gynecol Oncol; 2015 Jun; 137(3):546-52. PubMed ID: 25735255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
